Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,832 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Glofitamab plus gemcitabine and oxaliplatin (GemOx) versus rituximab-GemOx for relapsed or refractory diffuse large B-cell lymphoma (STARGLO): a global phase 3, randomised, open-label trial.
Abramson JS, Ku M, Hertzberg M, Huang HQ, Fox CP, Zhang H, Yoon DH, Kim WS, Abdulhaq H, Townsend W, Herbaux C, Zaucha JM, Zhang QY, Chang H, Liu Y, Cheah CY, Ghesquieres H, Simko S, Orellana-Noia V, Ta R, Relf J, Dixon M, Kallemeijn M, Mulvihill E, Huang H, Lundberg L, Gregory GP. Abramson JS, et al. Among authors: kim ws. Lancet. 2024 Nov 16;404(10466):1940-1954. doi: 10.1016/S0140-6736(24)01774-4. Lancet. 2024. PMID: 39550172 Clinical Trial.
A Phase 2 study of acimtamig (AFM13) in patients with CD30-positive, relapsed or refractory peripheral T-cell lymphomas.
Kim WS, Shortt J, Zinzani PL, Mikhailova N, Radeski D, Ribrag V, Domingo Domenech E, Sawas A, Alexis K, Emig M, Elbadri R, Hajela P, Ravenstijn P, Pinto S, Garcia L, Overesch A, Pietzko K, Horwitz S. Kim WS, et al. Clin Cancer Res. 2024 Nov 12. doi: 10.1158/1078-0432.CCR-24-1913. Online ahead of print. Clin Cancer Res. 2024. PMID: 39531538
Global outcomes and prognosis for relapsed/refractory mature T-cell and NK-cell lymphomas: Results from PETAL consortium.
Han JX, Koh MJ, Boussi L, Sorial M, McCabe SM, Peng L, Singh S, Eche-Ugwu IJ, Gabler J, Fernandez Turizo MJ, MacVicar CT, Garg AR, Disciullo A, Chopra K, Lenart AW, Nwodo E, Barnes JA, Koh MJ, Miranda ECM, Chiattone CS, Stuver RN, Horwitz SM, Merrill MH, Jacobsen ED, Manni M, Civallero M, Skrypets T, Lymboussaki A, Federico M, Kim YR, Kim JS, Cho JY, Eipe T, Shet T Dr, Epari S, Shetty A, Saha S, Jain H Dr, Sengar M MD, DM, Van Der Weyden C, Prince HM, Hamouche R, Muradashvili T, Foss FM, Gentilini M, Casadei B, Zinzani PL, Okatani T, Yoshida N, Yoon SE, Kim WS, Panchoo G, Mohamed Z, Verburgh E, Alturas JC, Al-Mansour M, Ford J, Cabrera ME, Ku A, Bhagat G, Ma H, Sawas A, Kariya KM, Iwasaki M, Bhanushali F, O'Connor OA, Marchi E, Shen C, Shah D, Jain S. Han JX, et al. Among authors: kim ws. Blood Adv. 2024 Oct 31:bloodadvances.2024014674. doi: 10.1182/bloodadvances.2024014674. Online ahead of print. Blood Adv. 2024. PMID: 39481087
Protecting our future: environmental hazards and children's health in the face of environmental threats: a comprehensive overview.
Lee J, Kim HB, Jung HJ, Chung M, Park SE, Lee KH, Kim WS, Moon JH, Lee JW, Shim JW, Lee SS, Kang Y, Yoo Y; Environmental Health Committee of the Korean Pediatric Society. Lee J, et al. Among authors: kim ws. Clin Exp Pediatr. 2024 Nov;67(11):589-598. doi: 10.3345/cep.2023.01578. Epub 2024 Oct 31. Clin Exp Pediatr. 2024. PMID: 39483040 Free PMC article.
2,832 results